LMW Q1 FY27 earnings call.
A source-linked concall view: reported numbers, management language, guidance, commitments and risks that should carry forward.
ConCallIQ research layer
Signal, with the source still visible.
Use the controls below to narrow the view, then follow the evidence into the next layer of context.
Revenue
₹861 Cr
verified against source
Revenue YoY
24%
reported change
EBITDA
Pending
latest reported figure
Source
screener in
record provenance
Actual signal trajectory
Where this quarter sits.
Quarter read
What the record says.
LMW reported Q1 FY27 standalone revenue of 891 crore, up 24% YoY, driven by strong performance in textile machinery (PMD: 482 crore, +16% YoY) and machine tools (MTD: 343 crore, +37% YoY). PBT surged 151% YoY to 85 crore. Management cited an order book of 3,200 crore for PMD (2,400 crore active), providing ~2 years visibility, while ATC holds 1,000 crore in orders over 3-3.5 years. Domestic demand is supported by state policies in Gujarat, Uttar Pradesh, and Madhya Pradesh, though capacity utilization remains ~60% in textiles. MTD faces margin pressure from input cost inflation (3-3.5% cost increase) and product mix shifts, operating at 75-80% utilization. The company announced an enabling resolution for potential diversification into pharma, chemicals, and advanced technology—management was evasive on specifics. ATC capex of 150 crore over 18-24 months is planned. Risks include customer concentration uncertainty, competitive dynamics, and input cost volatility not fully offset by pricing actions.
Colored figures show movement against the previous available record.
Guidance to track
- Building construction for ATC's new facility over 18-24 months to support scaling operations as order book extends to 1,000 crore.
- Current capacity utilization at 75-80% with headroom to scale without significant additional capex, supporting margin recovery as volume increases.
- Management expects spindle installations to pick up gradually driven by state policies and FDA benefits, not expecting sharp uptick but sustained improvement.
Risks flagged
- Sequential margin decline attributed to operational factors and cost inflation (3-3.5% cost increase). Price revision and localization efforts underway but timeline for margin recovery to 12-14% range not specified.
- Management gave vague response on enabling resolution for entering pharma, specialty chemicals, and advanced technology. No timeline, investment size, or strategic rationale provided despite direct analyst questioning.
- Cotton spinning margins are good but synthetic fiber producers face margin pressure, which could delay modernization capex decisions affecting order book conversion.
- Helium and specialty gas availability was a concern last quarter. While eased, management maintains 4-5 months material pipeline visibility as priority to ensure delivery commitments.
Key quotes
- We see there's a stability in which it is getting executed and that is where we are able to commit also yes there is a clarity of closer to thousand crores over next 3 years.
- The idea is that we are looking at various options which are available and this is an enabling resolution. Anything which is significant which needs to be informed definitely we'll bring it will get published.
Research modules